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Abstract
Background: To compare the characteristics and prognostic features of ischemic stroke in
patients with diabetes and without diabetes, and to determine the independent predictors of in-
hospital mortality in people with diabetes and ischemic stroke.
Methods: Diabetes was diagnosed in 393 (21.3%) of 1,840 consecutive patients with cerebral
infarction included in a prospective stroke registry over a 12-year period. Demographic
characteristics, cardiovascular risk factors, clinical events, stroke subtypes, neuroimaging data, and
outcome in ischemic stroke patients with and without diabetes were compared. Predictors of in-
hospital mortality in diabetic patients with ischemic stroke were assessed by multivariate analysis.
Results: People with diabetes compared to people without diabetes presented more frequently
atherothrombotic stroke (41.2% vs 27%) and lacunar infarction (35.1% vs 23.9%) (P < 0.01). The
in-hospital mortality in ischemic stroke patients with diabetes was 12.5% and 14.6% in those
without (P = NS). Ischemic heart disease, hyperlipidemia, subacute onset, 85 years old or more,
atherothrombotic and lacunar infarcts, and thalamic topography were independently associated
with ischemic stroke in patients with diabetes, whereas predictors of in-hospital mortality included
the patient's age, decreased consciousness, chronic nephropathy, congestive heart failure and atrial
fibrillation
Conclusion: Ischemic stroke in people with diabetes showed a different clinical pattern from
those without diabetes, with atherothrombotic stroke and lacunar infarcts being more frequent.
Clinical factors indicative of the severity of ischemic stroke available at onset have a predominant
influence upon in-hospital mortality and may help clinicians to assess prognosis more accurately.
Background
Diabetes mellitus is a well-established independent risk
factor for ischemic stroke [1]. Additionally, diabetes is the
cerebrovascular risk factor associated with greater in-hos-
pital mortality both in patients with ischemic stroke [2-5]
and intracerebral hemorrhage [6]. However, little is
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dictors of early mortality after an ischemic stroke in peo-
ple with diabetes. To improve our knowledge of ischemic
stroke in diabetes, we carried out a clinical study of
patients with diabetes and cerebral infarction collected
from an hospital-based stroke registry with the following
objectives: 1) to compare demographic data, clinical vari-
ables, stroke subtypes, and prognostic features of ischemic
stroke in patients with diabetes and without diabetes; and
2) to determine the independent predictors of in-hospital
mortality in people with diabetes and ischemic stroke.
Methods
Study population
Between January 1986 and December 1997, data of 2,500
acute stroke patients admitted consecutively to the
Department of Neurology of Sagrat Cor-Hospital of Barce-
lona, Spain were collected prospectively in a stroke regis-
try.[7] Our institution is an acute care 350-bed university-
affiliated hospital in the city of Barcelona and serves an
urban population of approximately 250,000 people. The
large majority of people are Caucasian. All patients with
cerebrovascular disease are initially attended to in the
emergency department and are then admitted to the
Department of Neurology, which has 25 beds and acute
stroke unit. Intensive care unit beds are also available.
Patients are chosen for admission to the Department of
Neurology if the reason for consultation is an acute cere-
brovascular event occurring independently of the pres-
ence or absence of severe concomitant medical problems.
Patients with transient ischemic attack (TIA) or reversible
neurologic deficits who are evaluated on an outpatient
basis are routinely referred to the emergency department
for assessment and included in the registry. Thus, the pro-
portion of patients experiencing minor strokes who are
not treated at the hospital is negligible. Subtypes of stroke
were classified according to the Cerebrovascular Study
Group of the Spanish Neurological Society [8], which is
similar to the National Institute of Neurological Disorders
and Stroke Classification [9] and has been used by our
group in previous studies [2,10,11]. Subtypes of cerebrov-
ascular accident included transient ischemic attack (TIA),
atherothrombotic stroke (n = 553), lacunar stroke (n =
484), cardioembolic infarction (n = 468), infarction of
undetermined origin (n = 248), infarction of unusual
cause (n = 87), intracerebral hemorrhage, subarachnoid
hemorrhage, spontaneous subdural hematoma, and
spontaneous epidural hematoma. For the purpose of this
study, the group of 1,840 patients with cerebral infarction
was selected.
All patients were admitted to the hospital within 48 hours
of onset of symptoms. On admission, demographic char-
acteristics, salient features of clinical and neurological
examination and results of laboratory tests (blood cell
count, biochemical profile, serum electrolytes, and urinal-
ysis), chest radiography, and twelve-lead electrocardiogra-
phy were recorded. Neurological examination was
performed on a daily basis. In all diabetic patients, brain
computed tomography scan was performed within this
first week of hospital admission. Cardiac investigations
included electrocardiogram in 100% (n = 393) of patients
and echocardiography in 32% (n = 125). Carotid investi-
gations consisted of Doppler and/or angio-magnetic reso-
nance imaging in 63.9% (n = 251) of patients, arterial
digital angiography in 7% (n = 28), and conventional ang-
iography 6.5% (n = 25). Lumbar puncture was performed
in 2% of cases. As used in previous studies [2,6], diabetic
patients were those with known diabetes, treated with
either insulin or oral hypoglycemic agents or not treated,
whatever the plasma glucose level at stroke onset. Patients
with post-stroke repeated fasting plasma glucose levels
>7.8 mmol/L (140 mg/dL) were enrolled in accordance
with the World Health Organization diagnostic criteria for
diabetes used in 1993 [12]. Patients with reactive hyperg-
lycemia were excluded. Serum determination of HbA1c
was performed in doubtful cases to diagnose previous
diabetes.
For each patient, demographic data (age and sex), vascular
risk factors, clinical features, neuroimaging findings, and
outcome were recorded. Anamnestic findings consisted of
history of hypertension, myocardial infarction or angina,
rheumatic heart disease, congestive heart failure, atrial
fibrillation, smoking, alcohol abuse, intermittent claudi-
cation, TIA, previous cerebral infarction, hyperlipidemia,
chronic nephropathy, cirrhosis or chronic liver disease,
chronic obstructive pulmonary disease (COPD), and age
of 85 years or older. Clinical variables, dichotomized as
present versus absent, included sudden onset of symp-
toms (< 60 min), acute onset (1–24 hours), and subacute
onset (> 24 hours); headache; dizziness; seizures; nausea
or vomiting; altered consciousness; limb weakness; sen-
sory symptoms; aphasia or dysarthria; ataxia; cranial
nerve palsy; and presence of lacunar syndrome (pure
motor hemiparesis, pure sensory stroke, sensorimotor
stroke, ataxic hemiparesis, and dysarthria-clumsy hand)
[13,14]. Topographic diagnoses based on data on neu-
roimaging variables also dichotomized as present versus
absent, included middle cerebral, posterior cerebral, ante-
rior cerebral artery involvement, and basilar and vertebral
artery involvement, and frontal, parietal, temporal, occip-
ital lobes, internal capsule, basal ganglia, thalamus, mid-
brain, and pons location. Outcome variables included
infectious complications and cardiac, respiratory, and vas-
cular events. Causes of death were analyzed according to
criteria of Silver et al. [15]. The degree of clinical disability
at hospital discharge was evaluated according to the scale
recommended by the Ad Hoc Committee [16] and the
modified Rankin Scale [17].Page 2 of 9
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Univariate analysis for each variable in relation to vital
status at discharge (alive, dead) as well as differences in
the frequency of demographic characteristics, vascular risk
factors, clinical events, neuroimaging data, and outcome
between ischemic stroke patients with and without diabe-
tes were assessed with the Student's t test and the chi-
square test (χ2) (with Yate's correction when necessary),
and the analysis of variance. Statistical significance was set
at P < 0.05. Variables associated with ischemic stroke in
patients with diabetes in the univariate analysis were sub-
jected to multivariate analysis with a logistic regression
procedure and forward stepwise selection if P < 0.10.
Ischemic stroke in diabetic patients coded as absent = 0,
present = 1, was the dependent variable. A first predictive
model was based on demographic variables and vascular
risk factors (total 8 variables). In addition to these varia-
bles, clinical features and ischemic stroke subtypes, --
dichotomized as present versus absent--, were included in
a second model (total 17 variables). In addition to these
variables, neuroimaging data, --also dichotomized as
present versus absent--, were included in a third model
(total 22 variables). In all cases, the level of significance to
remain in the model was 0.15. The tolerance level was
established as 0.0001. The maximum likelihood
approach was used to estimate weights of the logistic
parameters. Odds ratio (OR) and 95% confidence inter-
vals (CI) were calculated from the beta coefficients and
standard errors. The hypothesis that the logistic model
adequately fits the data was tested by means of the good-
ness-of-fit χ2 test [18]. The area under the receiver operat-
ing characteristics (ROC) curve for each predictive model
was calculated [19]. Cox proportional-hazards models
were used to estimate the relative risk of (RR) mortality
(with discharge alive for hospital as the censoring event
and death in hospital as the event of interest) after adjust-
ing for age, sex, cerebrovascular risk factors and clinical
findings, both in the group of diabetic and non-diabetic
stroke patients. Data are expressed as RR and 95% confi-
dence intervals (CIs). The SPSS-PC+ [20] and BMDP [21]
computer programs were used for statistical analysis.
Results
Diabetes was identified in 393 (21.3%) of the 1,840
ischemic stroke patients. A total of 51.4% of patients were
men. The mean age of diabetic patients with ischemic
stroke was 73.6 ± 9.8 years. Cardiovascular risk factors
included hypertension in 53.2% of cases atrial fibrillation
in 26.4%, hyperlipidemia in 15.3%, ischemic heart dis-
ease in 18.6%, chronic nephropathy in 4.8%, and conges-
tive heart failure in 2.7%. The frequency of stroke
subtypes was as follows: atherothrombotic infarction in
41.2% of patients, lacunar infarction in 35.1%, presumed
cardioembolic stroke in 18.6%, infarction of unknown
etiology in 4.3%, and infarction of unusual cause in 0.8%.
The in-hospital mortality was rate was 12.5% (n = 50).
Causes of death included cerebral herniation in 17
patients, cardiac events in 11, respiratory events in 10,
sepsis in 4, sudden death in 1, and unknown cause in 7.
Symptom-free at hospital discharge was observed in
18.1% of patients. The median hospital stay was 13 days
(interquartile range 8–21).
Differential features between people with and without
diabetes with ischemic stroke patients are shown in Table
1. Patients with diabetes compared to patients without
diabetes (n = 1,447) were more likely to have ischemic
heart disease, previous cerebral infarction, peripheral vas-
cular disease, hyperlipidemia, subacute stroke onset,
atherothrombotic and lacunar infarctions, and thalamus,
pons and cerebral posterior artery involvement. On the
other hand, they were less likely to be 85 years or older
and to have valvular heart disease, sudden stroke onset,
seizures, cardioembolic infraction, stroke of unusual
cause, stroke of unknown etiology, and parietal and tem-
poral lobe involvement. There were no differences in
medications used for the treatment of patients (patients
with diabetes vs patients without diabetes) antiplatelets
84.5% vs 85.4%, anticoagulants at therapeutic doses
(15.5% vs. 14.6%), antibiotic therapy (14.5% vs 12.6%),
and other medical treatments (96% vs 94%). After multi-
variate analysis (Table 2), ischemic heart disease, hyperli-
pidemia, atherothrombotic and lacunar infarcts, subacute
onset and thalamic infarcts were independently associ-
ated with diabetes in patients with ischemic stroke. Age of
85 years or older was inversely associated.
The characteristics of ischemic stroke patients with diabe-
tes according to vital status at discharge are shown in
Table 3. Patients who died (n = 50) compared to those
who were discharged alive from the hospital (n = 343)
had a significantly higher occurrence of the following var-
iables: age 85 years or older, atrial fibrillation, congestive
heart disease, chronic kidney disease, sudden and acute
stroke onset, seizures, decreased consciousness, limb
weakness, sensory deficit, hemianopia, atherothrombotic
stroke, cardioembolic infarction, parietal, temporal, inter-
nal capsule, mesencephalon and pons topography, basilar
and middle cerebral artery involvement, and cardiac, res-
piratory, urinary, digestive and infectious complications.
The relative risk for mortality in the groups of diabetic and
non-diabetic ischemic stroke patients is shown in Table 4.
Congestive heart disease, atrial fibrillation, decreased con-
sciousness, and age were significantly adversely associated
with outcome after acute ischemic stroke in both diabetic
and non-diabetic ischemic stroke patients. Chronic neph-
ropathy was a predictor of in-hospital mortality for the
group of diabetic ischemic stroke patients, whereas limb
weakness, nausea/vomiting, and seizures were predictorsPage 3 of 9
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stroke patients.
Discussion
In this hospital-based study of 1,840 consecutive patients
with acute ischemic stroke, the prevalence of diabetes was
21%, a figure similar to that reported in the studies of
Megherbi et al. [22] and Jorgensen et al. [4] and higher
than the prevalence of diabetes in the Spanish population
(6–7%) [23]. This may be explained by a stronger dispo-
sition to stroke in the diabetic patient, because diabetes
mellitus is associated with accelerated atherogenesis [24]
and also due to the fact that diabetic stroke patients have
more often other cerebrovascular risk factors as, in our
study, hyperlipidemia and ischemic heart disease, which
in turn were independent predictors of ischemic stroke in
the diabetic population as previously reported by others
[25,26]. The present results are consistent with the study
of Lehto et al. [25] in which hyperlipidemia was a strong
predictor of stroke in middle-aged patients with non-insu-
lin-dependent diabetes, probably because lipid abnor-
malities have been shown to be associated with cerebral
atherosclerosis [1,24].
With regard to data of our study in comparison to previ-
ous works [3-5,22,26-31], Table 5 shows that there are
only two previous studies [29,31] similar to ours. In the
study of Kiers et al. [29], however, stroke subtypes are dif-
ferentiated according to topography (cortical, lacunar,
striatocapsular, brainstem/cerebellar) and in the study of
Hamidon and Raymond [31] according to vascular topog-
raphy (anterior, middle, and posterior artery involve-
ment) and not according to cause (cardioembolic,
atherothrombotic, lacunar, unusual etiology, undeter-
mined cause) as in our report. In these two previous stud-
ies 50 and 90 patients were included as compared with
393 in our study. A strength of the present study is that
predictors of in-hospital mortality in patients with diabe-
tes and ischemic stroke were determined using logistic
regression analysis, but a limitation is that a follow-up
Table 1: Results of univariate analysis in diabetic patients with cerebral infarction as compared with patients with cerebral infarction 
without diabetes mellitus
Variable Patients with diabetes (n = 393) Patients without diabetes (n = 1,447) P value
Men 202 (51.4) 724 (50) 0.6313
Age, years, mean (SD) 73.6 (9.8) 74 (12.7) 0.4945
Age, 85 year or more 49 (12.5) 254 (17.6) 0.0159
Cardiovascular risk factors
Valvular heart disease 19 (4.8) 111 (7.7) 0.0517
Ischemic heart disease 73 (18.6) 193 (13.3) 0.0088
Previous cerebral infarction 77 (19.6) 223 (15.4) 0.0466
Peripheral vascular disease 39 (9.9) 103 (7.1) 0.0646
Hypelipidemia 89 (22.6) 241 (16.7) 0.0060
Clinical findings
Sudden onset 183 (46.3) 764 (52.8) 0.0225
Subacute onset (days) 40 (10.2) 90 (6.2) 0.0066
Seizures 3 (0.8) 31 (2.1) 0.0718
Lacunar syndrome 156 (39.7) 349 (27.2) <0.0001
Ischemic stroke subtypes
Atherothrombotic 162 (41.2) 391 (27) <0.0001
Cardioembolic 73 (18.6) 395 (27.3) 0.0004
Lacunar infarct 138 (35.1) 346 (23.9) <0.001
Unusual etiology 3 (0.8) 84 (5.8) <0.0001
Unknown cause 17 (4.3) 231 (16) <0.0001
Localization of cerebral infarction
Parietal 74 (18.8) 339 (23.4) 0.0527
Temporal 79 (20.1) 380 (26.3) 0.0123
Thalamus 44 (11.2) 88 (6.1) 0.0005
Pons 30 (7.6) 71 (4.9) 0.0353
Cerebral posterior involvement 52 (13.2) 128 (8.8) 0.0095
Outcome
Symptom free at discharge 71 (18.1) 272 (18.8) 0.4324
Hospital stay, days, median (interquartile range) 13 (8 to 21) 12 (8 to 21) 0.9752
In-hospital death 50 (12.5) 211 (14.6) 0.3488
Data as number and percentages in parenthesis except for the mean (SD) age and length of hospitalization.Page 4 of 9
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lower cut-point for the definition of hypertension (BP >
130/85 mm Hg), the prevalence of hypertension would
have been probably substantially greater.
Ischemic heart disease was another independent predictor
of ischemic stroke in diabetic patients. It could suggest
that diabetic patients have concurrent vascular lesions in
the heart and the brain due to widespread atherosclerotic
disease. In the study of Manson et al. [32], maturity-onset
clinical diabetes was a independent risk factor for coro-
nary heart disease.
Subacute stroke onset (> 24 hours) was found to be a pre-
dictive clinical factor in diabetic ischemic stroke. This may
be because thrombotic occlusion usually is gradual, and
thrombotic infarcts show more frequently a fluctuating or
progressive clinical course [33]. In contrast, sudden stroke
onset is more characteristic of cardioembolic infarction
and was observed in 83% of cases in the series of
Bogousslavsky et al. [34] and in 79% of patients reported
by Mohr et al. [35].
In our diabetic group, the distribution of pathological
subtypes of ischemic stroke showed a higher occurrence of
atherothrombotic and lacunar infarctions compared to
nondiabetic ischemic stroke patients. Atherothrombotic
infarcts were the most frequent stroke subtype (41.2%).
This high frequency may be related to the increased sus-
ceptibility to atherosclerosis and the accelerated athero-
genesis associated with diabetes mellitus.[1,24] Other
authors found that diabetes was more frequently associ-
ated with angiographically demonstrated extracranial
atherosclerotic carotid artery occlusion and
atherosclerotic occlusive disease of the basilar artery, with
a strong association between diabetes and carotid artery
intimal-medial thickness [1,24]. The fact that we observed
more lacunar infarcts in diabetic patients has been
reported by our group in a previous study[2] and has been
also observed in another recent series [22]. Diabetes can
cause small vessel arteriolopathy, especially in the retina,
kidney and brain (mainly in thalamus, internal capsule
and pons topography) [36,37]. In a classical autopsy
study of cerebrovascular accident in diabetes mellitus,
Alex et al. [38] found that small vessel cerebral disease was
present about 2.5 times more frequent in diabetes.
At discharge, the case fatality rate in the two groups of dia-
betic and nondiabetic ischemic stroke patients was com-
parable (12.5% and 14.6%, respectively). In our opinion,
the increased occurrence of lacunar infarcts in diabetic
patients, with a known good prognosis [36,37] (0% of in-
hospital mortality in our study), may account for the lack
of differences in early mortality. Functional recovery after
lacunar infarcts as well as survival has been found to be
favorable [38-40] and in a recent study [41], lacunar
stroke had an odds ratio of 3.1 for an excellent outcome at
3 months.
Table 2: Independent factors associated with diabetes in patients with ischemic stroke.
Logistic regression models β SE (β) Odds ratio (95% CI)
Demographic, and vascular risk factors *
Ischemic heart disease 0.386 0.152 1.47 (1.09–1.98)
Hyperlipidemia 0.354 0.141 1.42 (1.08–1.88)
85 years old or more -0.351 0.169 0.70 (0.50–0.98)
Demographic, vascular risk factors, clinical variables and ischemic stroke subtypes†
Atherothrombotic infarct 1.910 0.250 6.75 (4.14–11.02)
Lacunar infarct 1.900 0.254 6.68 (4.07–10.99)
Subacute onset (days) 0.590 0.213 1.80 (1.19–2.74)
85 years old or more -0.391 0.172 0.68 (0.48–0.95)
Demographic, vascular risk factors, clinical variables and neuroimaging data‡
Atherothrombotic 1.929 0.250 6.88 (4.21–11.24)
Lacunar infarct 1.848 0.255 6.35 (3.85–10.46)
Subacute onset (days) 0.601 0.213 1.82 (1.20–2.77)
Thalamic topography 0.557 0.204 1.74 (1.17–2.61)
85 years old or more -0.381 0.172 0.683 (0.49–0.96)
* β = -1.381, SE (β) = 0.074, goodness of fit χ2 = 0.434, df = 3, P = 0.933. Area under the ROC curve = 0.563, sensitivity 28%, specificity 81%, 
correctly classified 67%.
† β = -2.802, SE (β) = 0.235, goodness of fit χ2 = 2.133, df = 4, P = 0.711. Area under the ROC curve = 0.663, sensitivity 29%, specificity 88%, 
correctly classified 55%.
‡ β = -2.847, SE (β) = 0.236, goodness of fit χ2 = 3.151, df = 5, P = 0.677. Area under the ROC curve = 0.671, sensitivity 30%, specificity 50%, 
correctly classified 42%.Page 5 of 9
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related to in-hospital mortality in diabetic patients with
ischemic stroke were age, atrial fibrillation, congestive
heart failure, chronic nephropathy and altered conscious-
ness. Baseline plasma glucose level, which is a variable
associated with poor outcome in stroke was not assessed.
In the present study, like others [42], decreased conscious-
ness and age were important clinical predictors of early
mortality. In the study of Hamidon and Raymond [31],
middle cerebral artery territory infarct and poor conscious
level were independent predictors of mortality. Atrial
fibrillation was another major aggravating factor in this
population. Atrial fibrillation increases the risk of early
recurrent stroke substantially and patients with atrial
fibrillation may have larger infarcts [43]. In addition,
atrial fibrillation may be a cause of more severe handicap
through more severe motor or sensory deficits. Diabetic
patients who died also tended to show a more severe neu-
rological impairment at onset, characterized by a predom-
inance of motor deficit and decreased consciousness,
which is similar to results of the study of Olsson et al. [3].
The presence of congestive heart failure was another sig-
nificant prognostic factor. This finding is similar to other
studies [44,45] who reported a high mortality among
patients with embolic stroke and ischemic heart diseases
or congestive heart failure. Our results agree with the
study of MacWalter et al. [46] who demonstrate that renal
dysfunction had a higher mortality risk after acute stroke.
Table 3: Results of univariate analysis in 393 diabetic patients with cerebral infarction according to vital status at discharge
Variable Dead (n = 50) Alive (n = 343) P value
Men 18 (36) 184 (53.6) 0.0197
Age, years, mean (SD) 78.4 (7.2) 72.9 (9.9 0.0002
Age, 85 years or more 13 (26) 36 (10.5) 0.0019
Cardiovascular risk factors
Atrial fibrillation 26 (52) 78 (22.7) <0.0001
Congestive heart disease 6 (12) 13 (3.8) 0.0296
Chronic nephropathy 4 (8) 7 (2) 0.0389
Clinical findings
Sudden onset 32 (64) 150 (43.7) 0.0072
Acute onset (hours) 11 (22) 122 (35.6) 0.0582
Seizures 2 (4) 1 (0.3) 0.0518
Decreased consciousness 31 (62) 29 (8.5) <0.0001
Limb weakness 48 (96) 249 (72.6) 0.0003
Sensory symptoms 33 (66) 130 (37.9) 0.0002
Hemianopia 17 (34) 54 (15.7) 0.0017
Lacunar syndrome 0 156 (45.5) <0.0001
Ischemic stroke subtypes
Atherothrombotic 29 (58) 1333 (38.8) 0.0988
Cardioembolic 19 (38) 54 (15.7) 0.0016
Lacunar infarct 0 138 (40.2) <0.0001
Unusual etiology 0 3 (0.9) 1.0000
Unknown cause 2 (4) 15 (4.4) 1.0000
Localization of cerebral infarction
Parietal 24 (48) 50 (14.6) <0.0001
Temporal 22 (44) 57 (16.6) 0.0001
Internal capsule 4 (8) 77 (22.4) 0.0183
Mesencephalon 4 (8) 1 (0.3) <0.0001
Pons 8 (16) 22 (6.4) 0.0171
Middle cerebral artery involvement 31 (62) 166 (48.4) 0.0723
Basilar artery involvement 9 (18) 23 /6.7) 0.0142
Outcome
Respiratory complications 19 (38) 19 (5.5) <0.0001
Digestive complications 4 (8) 5 (1.5) 0.0172
Urinary infections 9 (18) 30 (8.7) 0.0732
Cardiac complications 15 (30) 8 (2.3) <0.0001
Infectious complications 16 (32) 33 (9.6) <0.0001
Hospital stay, days, median (interquartile range) 13 (8 to 21) 12 (8 to 21) 0.9752
Data as number and percentages in parenthesis except for median (interquartile range) for hospitalization.Page 6 of 9
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stroke [47]. However renal dysfunction represents the
influence of generalized vascular disease in the kidney
and is a potent predictor of in-hospital mortality in acute
ischemic stroke diabetic people.
Conclusion
In the present series of ischemic stroke patients with dia-
betes collected from a prospective hospital-based stroke
registry, the clinical picture of these patients was charac-
terized by a more frequent concomitant ischemic heart
disease and hyperlipidemia and a more frequent presence
Table 4: Risk for in-hospital mortality in ischemic stroke patients with diabetes and without diabetes. Cox's proportional hazards 
model.
Predictors of death Hazard ratio P value 95% CI
Diabetic stroke patients
Demographic variables and vascular risk factors (model 1)
Chronic nephropathy 5.78 0.001 1.99–16.80
Congestive heart disease 2.52 0.045 1.02–6.23
Atrial fibrillation 2.39 0.003 1.36–4.20
Age 1.06 0.002 1.02–1.10
Demographic variables, vascular risk factors, clinical variables, and stroke subtypes (model 2)
Decreased consciousness 5.16 0.000 2.82–9.42
Congestive heart disease 4.08 0.002 1.65–10.09
Chronic nephropathy 3.27 0.036 1.08–9.89
Atrial fibrillation 2.41 0.002 1.38–4.23
Non-diabetic stroke patients
Demographic variables and vascular risk factors (model 1)
Congestive heart disease 2.00 0.001 1.35–2.96
Atrial fibrillation 1.83 0.000 1.38–2.43
Ischemic heart disease 1.74 0.002 1.23–2.58
Age 1.04 0.000 1.03–1.06
Demographic variables, vascular risk factors, clinical variables, and stroke subtypes (model 2)
Decreased consciousness 4.58 0.000 3.39–6.19
Limb weakness 1.93 0.038 1.04–3.59
Nausea/vomiting 1.79 0.009 1.16–2.76
Seizures 1.75 0.047 1.01–3.03
Congestive heart disease 1.74 0.006 1.17–2.59
Ischemic heart disease 1.72 0.003 1.02–1.80
Atrial fibrillation 1.35 0.039 1.02–1.80
Age 1.03 0.000 1.02–1.05
Table 5: Ischemic stroke and diabetes. Series reported in the literature
1st author, year No. patients with 
ischemic stroke 
and diabetes
Type of study Ischemic stroke 
subtypes
Predictors of in-
hospital death
Follow-up 
survival analysis
Asplund [27], 1980 53 Retrospective No No No
Oppenheimer [5], 1985 14 Retrospective No No No
Lithner [26], 1988 75 Retrospective No No No
Woo [28], 1990 47 Cross-sectional Yes No No
Olsson [3], 1990 121 Prospective No No Yes (0–10 yr)
Kiers [29], 1992 50 Prospective Yes Yes No
Jorgensen [4], 1994 233 Prospective, community-based stroke 
registry
No Yes No
Weir [30], 1997 61 Prospective No No Yes (3 mo)
Megherbi [22], 2003 937 Prospective multicenter No No Yes (3 mo)
Hamidon [31], 2003 90 Prospective No Yes No
Present series, 2004 393 Prospective, hospital.-based stroke registry Yes Yes NoPage 7 of 9
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with ischemic stroke in people without diabetes. The in-
hospital mortality is related to the presence of causal fac-
tors for stroke, including a more diffuse atherosclerotic
disease and atrial fibrillation, and a higher frequency of
other factors including a more advanced age, a strategic
ischemic stroke in midbrain or large cortical topography,
and the occurrence of cardiac or respiratory complications
after stroke.
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